Epstein-Barr Virus Epitope–Major Histocompatibility Complex Interaction Combined with Convergent Recombination Drives Selection of Diverse T Cell Receptor α and β Repertoires

ABSTRACT Recognition modes of individual T cell receptors (TCRs) are well studied, but factors driving the selection of TCR repertoires from primary through persistent human virus infections are less well understood. Using deep sequencing, we demonstrate a high degree of diversity of Epstein-Barr vi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Anna Gil, Larisa Kamga, Ramakanth Chirravuri-Venkata, Nuray Aslan, Fransenio Clark, Dario Ghersi, Katherine Luzuriaga, Liisa K. Selin
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2020
Materias:
TCR
EBV
Acceso en línea:https://doaj.org/article/2b7944df77564095993254270d153052
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:2b7944df77564095993254270d153052
record_format dspace
spelling oai:doaj.org-article:2b7944df77564095993254270d1530522021-11-15T15:57:02ZEpstein-Barr Virus Epitope–Major Histocompatibility Complex Interaction Combined with Convergent Recombination Drives Selection of Diverse T Cell Receptor α and β Repertoires10.1128/mBio.00250-202150-7511https://doaj.org/article/2b7944df77564095993254270d1530522020-04-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.00250-20https://doaj.org/toc/2150-7511ABSTRACT Recognition modes of individual T cell receptors (TCRs) are well studied, but factors driving the selection of TCR repertoires from primary through persistent human virus infections are less well understood. Using deep sequencing, we demonstrate a high degree of diversity of Epstein-Barr virus (EBV)-specific clonotypes in acute infectious mononucleosis (AIM). Only 9% of unique clonotypes detected in AIM persisted into convalescence; the majority (91%) of unique clonotypes detected in AIM were not detected in convalescence and were seeming replaced by equally diverse “de novo” clonotypes. The persistent clonotypes had a greater probability of being generated than nonpersistent clonotypes due to convergence recombination of multiple nucleotide sequences to encode the same amino acid sequence, as well as the use of shorter complementarity-determining regions 3 (CDR3s) with fewer nucleotide additions (i.e., sequences closer to germ line). Moreover, the two most immunodominant HLA-A2-restricted EBV epitopes, BRLF1109 and BMLF1280, show highly distinct antigen-specific public (i.e., shared between individuals) features. In fact, TCRα CDR3 motifs played a dominant role, while TCRβ played a minimal role, in the selection of TCR repertoire to an immunodominant EBV epitope, BRLF1. This contrasts with the majority of previously reported repertoires, which appear to be selected either on TCRβ CDR3 interactions with peptide/major histocompatibility complex (MHC) or in combination with TCRα CDR3. Understanding of how TCR-peptide-MHC complex interactions drive repertoire selection can be used to develop optimal strategies for vaccine design or generation of appropriate adoptive immunotherapies for viral infections in transplant settings or for cancer. IMPORTANCE Several lines of evidence suggest that TCRα and TCRβ repertoires play a role in disease outcomes and treatment strategies during viral infections in transplant patients and in cancer and autoimmune disease therapy. Our data suggest that it is essential that we understand the basic principles of how to drive optimum repertoires for both TCR chains, α and β. We address this important issue by characterizing the CD8 TCR repertoire to a common persistent human viral infection (EBV), which is controlled by appropriate CD8 T cell responses. The ultimate goal would be to determine if the individuals who are infected asymptomatically develop a different TCR repertoire than those that develop the immunopathology of AIM. Here, we begin by doing an in-depth characterization of both CD8 T cell TCRα and TCRβ repertoires to two immunodominant EBV epitopes over the course of AIM, identifying potential factors that may be driving their selection.Anna GilLarisa KamgaRamakanth Chirravuri-VenkataNuray AslanFransenio ClarkDario GhersiKatherine LuzuriagaLiisa K. SelinAmerican Society for MicrobiologyarticlerepertoireT cell receptorTCREpstein-Barr virusEBVacute infectious mononucleosisMicrobiologyQR1-502ENmBio, Vol 11, Iss 2 (2020)
institution DOAJ
collection DOAJ
language EN
topic repertoire
T cell receptor
TCR
Epstein-Barr virus
EBV
acute infectious mononucleosis
Microbiology
QR1-502
spellingShingle repertoire
T cell receptor
TCR
Epstein-Barr virus
EBV
acute infectious mononucleosis
Microbiology
QR1-502
Anna Gil
Larisa Kamga
Ramakanth Chirravuri-Venkata
Nuray Aslan
Fransenio Clark
Dario Ghersi
Katherine Luzuriaga
Liisa K. Selin
Epstein-Barr Virus Epitope–Major Histocompatibility Complex Interaction Combined with Convergent Recombination Drives Selection of Diverse T Cell Receptor α and β Repertoires
description ABSTRACT Recognition modes of individual T cell receptors (TCRs) are well studied, but factors driving the selection of TCR repertoires from primary through persistent human virus infections are less well understood. Using deep sequencing, we demonstrate a high degree of diversity of Epstein-Barr virus (EBV)-specific clonotypes in acute infectious mononucleosis (AIM). Only 9% of unique clonotypes detected in AIM persisted into convalescence; the majority (91%) of unique clonotypes detected in AIM were not detected in convalescence and were seeming replaced by equally diverse “de novo” clonotypes. The persistent clonotypes had a greater probability of being generated than nonpersistent clonotypes due to convergence recombination of multiple nucleotide sequences to encode the same amino acid sequence, as well as the use of shorter complementarity-determining regions 3 (CDR3s) with fewer nucleotide additions (i.e., sequences closer to germ line). Moreover, the two most immunodominant HLA-A2-restricted EBV epitopes, BRLF1109 and BMLF1280, show highly distinct antigen-specific public (i.e., shared between individuals) features. In fact, TCRα CDR3 motifs played a dominant role, while TCRβ played a minimal role, in the selection of TCR repertoire to an immunodominant EBV epitope, BRLF1. This contrasts with the majority of previously reported repertoires, which appear to be selected either on TCRβ CDR3 interactions with peptide/major histocompatibility complex (MHC) or in combination with TCRα CDR3. Understanding of how TCR-peptide-MHC complex interactions drive repertoire selection can be used to develop optimal strategies for vaccine design or generation of appropriate adoptive immunotherapies for viral infections in transplant settings or for cancer. IMPORTANCE Several lines of evidence suggest that TCRα and TCRβ repertoires play a role in disease outcomes and treatment strategies during viral infections in transplant patients and in cancer and autoimmune disease therapy. Our data suggest that it is essential that we understand the basic principles of how to drive optimum repertoires for both TCR chains, α and β. We address this important issue by characterizing the CD8 TCR repertoire to a common persistent human viral infection (EBV), which is controlled by appropriate CD8 T cell responses. The ultimate goal would be to determine if the individuals who are infected asymptomatically develop a different TCR repertoire than those that develop the immunopathology of AIM. Here, we begin by doing an in-depth characterization of both CD8 T cell TCRα and TCRβ repertoires to two immunodominant EBV epitopes over the course of AIM, identifying potential factors that may be driving their selection.
format article
author Anna Gil
Larisa Kamga
Ramakanth Chirravuri-Venkata
Nuray Aslan
Fransenio Clark
Dario Ghersi
Katherine Luzuriaga
Liisa K. Selin
author_facet Anna Gil
Larisa Kamga
Ramakanth Chirravuri-Venkata
Nuray Aslan
Fransenio Clark
Dario Ghersi
Katherine Luzuriaga
Liisa K. Selin
author_sort Anna Gil
title Epstein-Barr Virus Epitope–Major Histocompatibility Complex Interaction Combined with Convergent Recombination Drives Selection of Diverse T Cell Receptor α and β Repertoires
title_short Epstein-Barr Virus Epitope–Major Histocompatibility Complex Interaction Combined with Convergent Recombination Drives Selection of Diverse T Cell Receptor α and β Repertoires
title_full Epstein-Barr Virus Epitope–Major Histocompatibility Complex Interaction Combined with Convergent Recombination Drives Selection of Diverse T Cell Receptor α and β Repertoires
title_fullStr Epstein-Barr Virus Epitope–Major Histocompatibility Complex Interaction Combined with Convergent Recombination Drives Selection of Diverse T Cell Receptor α and β Repertoires
title_full_unstemmed Epstein-Barr Virus Epitope–Major Histocompatibility Complex Interaction Combined with Convergent Recombination Drives Selection of Diverse T Cell Receptor α and β Repertoires
title_sort epstein-barr virus epitope–major histocompatibility complex interaction combined with convergent recombination drives selection of diverse t cell receptor α and β repertoires
publisher American Society for Microbiology
publishDate 2020
url https://doaj.org/article/2b7944df77564095993254270d153052
work_keys_str_mv AT annagil epsteinbarrvirusepitopemajorhistocompatibilitycomplexinteractioncombinedwithconvergentrecombinationdrivesselectionofdiversetcellreceptoraandbrepertoires
AT larisakamga epsteinbarrvirusepitopemajorhistocompatibilitycomplexinteractioncombinedwithconvergentrecombinationdrivesselectionofdiversetcellreceptoraandbrepertoires
AT ramakanthchirravurivenkata epsteinbarrvirusepitopemajorhistocompatibilitycomplexinteractioncombinedwithconvergentrecombinationdrivesselectionofdiversetcellreceptoraandbrepertoires
AT nurayaslan epsteinbarrvirusepitopemajorhistocompatibilitycomplexinteractioncombinedwithconvergentrecombinationdrivesselectionofdiversetcellreceptoraandbrepertoires
AT fransenioclark epsteinbarrvirusepitopemajorhistocompatibilitycomplexinteractioncombinedwithconvergentrecombinationdrivesselectionofdiversetcellreceptoraandbrepertoires
AT darioghersi epsteinbarrvirusepitopemajorhistocompatibilitycomplexinteractioncombinedwithconvergentrecombinationdrivesselectionofdiversetcellreceptoraandbrepertoires
AT katherineluzuriaga epsteinbarrvirusepitopemajorhistocompatibilitycomplexinteractioncombinedwithconvergentrecombinationdrivesselectionofdiversetcellreceptoraandbrepertoires
AT liisakselin epsteinbarrvirusepitopemajorhistocompatibilitycomplexinteractioncombinedwithconvergentrecombinationdrivesselectionofdiversetcellreceptoraandbrepertoires
_version_ 1718427019686969344